Goldman Sachs Group Inc Cellebrite Di Ltd. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 341,641 shares of CLBT stock, worth $6.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
341,641
Previous 112,946
202.48%
Holding current value
$6.17 Million
Previous $2.19 Million
149.13%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding CLBT
# of Institutions
216Shares Held
99.2MCall Options Held
122KPut Options Held
80.8K-
True Wind Capital Management, L.P.13.9MShares$250 Million93.81% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.52MShares$118 Million0.07% of portfolio
-
Voss Capital, LLC Houston, TX5.15MShares$93 Million6.92% of portfolio
-
Morgan Stanley New York, NY4.65MShares$84 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.51MShares$63.3 Million0.01% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.42B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...